• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
PPY
Click for more information
10.0% 1.1¢

PAPYRUS AUSTRALIA LIMITED - Corporate Spotlight

Market Cap $5.419M  ! watchlist Created with Sketch. Add to my watchlist
Forest Products Paper & Paper Products

Papyrus Australia Ltd is an Australia-based technology licensing company. The Company is... Papyrus Australia Ltd is an Australia-based technology licensing company. The Company is focused on developing partnerships with local organizations in banana growing regions, to establish banana processing facilities for the conversion of banana plantation waste into molded food packaging products. It has created a mechanical process that converts banana plantation waste into commercial quantities of banana fiber pulp, fertilizer, food packaging and other consumable products. It operates two commercial-scale facilities in Egypt, including a processing plant converting banana waste into pulp and fertilizer and a separate facility converting pulp into food packaging products using fiber molding machines. It produces products from existing agricultural-waste, using a zero-waste process. It produces commercial quantities of biodegradable molded food packaging using off-the-shelf molding machines. Its technology converts banana tree waste into useable products, such as liquid fertilizer.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

No Corporate Spotlight currently available.

(20min delay)
Last
1.1¢ 		Change
0.001(10.0%) 		Mkt cap ! $5.419M
Open High Low Value Volume
1.1¢ 1.1¢ 1.1¢ $303 27.5K

Buyers (Bids)

No. Vol. Price($)
1 164210 0.9¢
 

Sellers (Offers)

Price($) Vol. No.
1.0¢ 60777 1
View Market Depth
Last trade - 10.06am 03/10/2024 (20 minute delay) ?
PPY (ASX) Chart

Top Stories

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Lumos gains US govt support for study on FebriDx bacterial infection test Lumos Diagnostics Holdings Ltd has seen its share price more than 10% on news of the partnership with a US government body
Superior finds multi-lode shoot system at QLD's Steam Engine gold play Superior Resources Ltd has found a multi-lode gold shoot system through drilling at its Steam Engine play in Queensland
Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.